H-1202 |
? |
C25H37N5O8 |
535.60 |
137372-00-0 |
Ac-Thr-Leu-Asn-Phe-OH |
H-1203 |
? |
C36H49N7O11 |
755.83 |
150626-30-5 |
Ac-Thr-Val-Ser-Phe-Asn-Phe-OH |
H-1204 |
Anthranilyl-HIV Protease Substrate |
C43H65N13O11 |
940.07 |
133233-38-2 |
Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH2 |
H-1205 |
Anthranilyl-HIV Protease Substrate III |
C65H100N20O17 |
1433.63 |
138668-80-1 |
Abz-His-Lys-Ala-Arg-Val-Leu-p-nitro-Phe-Glu-Ala-Nle-Ser-NH2 |
H-1206 |
Anthranilyl-HIV Protease Substrate IV |
C56H88N16O14 |
1209.41 |
141223-69-0 |
Abz-Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
H-1207 |
Anthranilyl-HIV Protease Substrate V |
C50H76N14O13 |
1081.24 |
210644-48-7 |
Abz-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
H-1208 |
Anthranilyl-HIV Protease Substrate VI |
C47H71N13O12 |
1010.16 |
210644-49-8 |
Abz-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
H-1209 |
? |
C93H156N26O19S2 |
2006.56 |
118720-30-2 |
H-Lys-Arg-Trp-Ile-Ile-Leu-Gly-Leu-Asn-Lys-Ile-Val-Arg-Met-Tyr-Cys-OH |
H-1210 |
(Cys(Bzl)84)-CD4 (81-92) |
C69H102N14O26S |
1575.71 |
123380-68-7 |
H-Thr-Tyr-Ile-Cys(Bzl)-Glu-Val-Glu-Asp-Gln-Lys-Glu-Glu-OH |
H-1211 |
(Cys(Bzl)84,Glu(OBzl)85)-CD4 (81-92) |
C76H108N14O26S |
1665.84 |
? |
H-Thr-Tyr-Ile-Cys(Bzl)-Glu(OBzl)-Val-Glu-Asp-Gln-Lys-Glu-Glu-OH |